机械转化
心肌梗塞
细胞外基质
整合素
血栓反应蛋白
阿达姆斯
细胞生物学
医学
下调和上调
血栓反应素
基因剔除小鼠
基质金属蛋白酶
心脏病学
病态的
血管生成
表型
癌症研究
赖氨酰氧化酶
化学
成纤维细胞
血栓反应蛋白1
焦点粘着
蛋白多糖
发病机制
信号转导
心功能曲线
内皮功能障碍
动脉发生
时间1
生物
作者
Chun‐Yan Kong,Zhen Guo,Yulan Ma,Mingyu Wang,Haiyang Ni,Pan Wang,Wen‐Jun Qiu,Engui Wang,Zhou Li,Yang Zheng,Bo Shen,Qizhu Tang
标识
DOI:10.1002/advs.202504138
摘要
-Myocardial infarction (MI) remains a leading cause of morbidity and mortality worldwide, with post-infarction cardiac remodeling, particularly excessive scar formation, representing a critical determinant of patient outcomes. However, the mechanistic pathways governing pathological scar formation remain incompletely understood. Here, we demonstrate that ADAMTS1 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs 1), significantly upregulated in endothelial cells (ECs) following MI, plays a pivotal role in regulating cardiac fibroblast activation through a novel mechanotransduction pathway involving integrin α8 (ITGα8). Using EC-specific ADAMTS1 overexpression and knockout mice combined with cardiac fibroblast-specific ITGα8 deletion models, we found that ADAMTS1 overexpression exacerbates cardiac dysfunction and increases scar size, while ADAMTS1 deficiency provides cardioprotection. Mechanistically, ADAMTS1 modulates extracellular matrix stiffness through proteoglycan (PG) cleavage rather than direct protein interactions, which activates ITGα8 mechanosensing specifically in cardiac fibroblasts. Among integrin family members tested, ITGα8 shows selective responsiveness to ADAMTS1-mediated mechanical cues, as confirmed by tunable-stiffness hydrogel experiments and validated through comprehensive proteomic and functional analyses. ITGα8 deficiency rescues ADAMTS1-induced cardiac dysfunction and reduces pathological scar formation. These findings reveal a previously unrecognized ADAMTS1-ITGα8 mechanotransduction pathway, representing a promising therapeutic target for optimizing post-infarction cardiac remodeling.
科研通智能强力驱动
Strongly Powered by AbleSci AI